These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
485 related articles for article (PubMed ID: 33858382)
1. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma. Ma X; Ding Y; Zeng L BMC Cancer; 2021 Apr; 21(1):418. PubMed ID: 33858382 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma. Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005 [No Abstract] [Full Text] [Related]
3. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma. Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731 [TBL] [Abstract][Full Text] [Related]
4. Exploring the Prognostic Value, Immune Implication and Biological Function of Huang Y; Huang S; Ma L; Wang Y; Wang X; Xiao L; Qin W; Li L; Yuan X Front Immunol; 2021; 12():723293. PubMed ID: 34899687 [TBL] [Abstract][Full Text] [Related]
5. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma. Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394 [TBL] [Abstract][Full Text] [Related]
7. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma. Zhang Y; Liu X; Liu L; Chen J; Hu Q; Shen S; Zhou Y; Chen S; Xue C; Cui G; Yu Z Dis Markers; 2020; 2020():2514090. PubMed ID: 32399086 [TBL] [Abstract][Full Text] [Related]
10. Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data. Zeng Z; Cao Z; Zhang E; Huang H; Tang Y Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33346796 [TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma. He D; Liao S; Cai L; Huang W; Xie X; You M BMC Cancer; 2021 May; 21(1):599. PubMed ID: 34034705 [TBL] [Abstract][Full Text] [Related]
12. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data. Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866 [TBL] [Abstract][Full Text] [Related]
13. A novel multidimensional signature predicts prognosis in hepatocellular carcinoma patients. Wang S; Zhang JH; Wang H; Yang L; Hong S; Yu B; Guo JC; Liu J; Zhu YB J Cell Physiol; 2019 Jul; 234(7):11610-11619. PubMed ID: 30480822 [TBL] [Abstract][Full Text] [Related]
14. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma. Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387 [TBL] [Abstract][Full Text] [Related]
15. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma. Yan J; Zhou C; Guo K; Li Q; Wang Z J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981 [TBL] [Abstract][Full Text] [Related]
16. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma. Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013 [TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study. Wang Y; Huang Q; Deng T; Li BH; Ren XQ Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma. Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898 [TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas. Li J; Chen N; Gong X Mol Med Rep; 2019 Dec; 20(6):5304-5314. PubMed ID: 31661127 [TBL] [Abstract][Full Text] [Related]
20. Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients. Huo X; Qi J; Huang K; Bu S; Yao W; Chen Y; Nie J BMC Cancer; 2020 Aug; 20(1):771. PubMed ID: 32807131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]